Loading
Latest filing published 03 Oct 2022 for Reviva Pharmaceuticals Holdings, INC., €84k.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
All filings by Prabhu Narayan on record concern Reviva Pharmaceuticals Holdings, Inc., in the capacity of finance chief. We count 2 filings; the first trade dates from 30 June 2022 and the latest from 30 September 2022.
On the market, this insider has only ever bought: 2 purchases, €142k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 3 October 2022, reports an open-market purchase of €84k in Reviva Pharmaceuticals Holdings, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations